Pharmacokinetic and Biodistribution Studies

Based on Grann’s own experiences with FDA, Grann has intimate knowledge on how FDA, and CBER in particular, want your pharmacokinetic, biodistribution, and toxicology studies to be performed and which data points they view as most important. Grann’s team is fully equipped to run any pre-clinical pharmacokinetic, biodistribution, or toxicology studies performed in mice which FDA requires you to perform. Lead time depends on the length of required animal study. Inquire for further details.